UCB to Invest $2 Billion in Georgia, Establish First U.S. Manufacturing Facility
On Mar. 24, 2026, Governor Brian P. Kemp announced that global biopharmaceutical giant UCB, is planning a significant…
-
-
CDC Study Finds Candida auris is an urgent public health threat
On Feb. 9, 2026, a study from Centers for Disease Control and Prevention (CDC) finds Candida auris is…
-
CDC Reports 2024-25 COVID vaccine 79% effective against death, 40% against hospitalization
On Feb. 4, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported the 2024-25 COVID-19 vaccine was…
-
CDC | Infectious Disease | Influenza | Measles | Polio | Vaccine | Women's Health
Confusion surrounds CDC’s ‘shared clinical decision-making’ paradigm for childhood vaccines
On Jan. 6, 2025, the Centers for Disease Control and Prevention (CDC) said “shared clinical decision-making” would be…
-
US measles outbreak tops 2,000 known infections
On Dec. 29, 2025, measles cases nationwide have reached 2,012, the Centers for Disease Control and Prevention (CDC)…
-
CDC | Clinical Research | HIV | Infectious Disease | Medicine | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Veterinary
U.S. Centers for Disease Control and Prevention to End Monkey Research Program
On Nov. 21, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced it has instructed staffers…
-
CDC | NIH | U.S. Congress
NEJM and public health group are launching rival to CDC’s MMWR publication
On Oct. 21, 2025, in the latest bid to plug gaps in the federal government’s public health infrastructure,…
-
ACG to invest $200 million in U.S. hard-shell capsule manufacturing
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
-
CDC | COVID-19 | Infectious Disease | Influenza | Measles | NIH | Non-Profit Research | U.S. Congress | Vaccine | Women's Health
U.S. CDC chief exits after weeks in role, three top officials resign
On Aug. 27, 2025, the U.S. Centers for Disease Control and Prevention (CDC) Director Susan Monarez has left…
-
Georgia State Scientists Revive Ancient Gene to Target Gout, Fatty Liver Disease
On Aug. 26, 2025, scientists at Georgia State University (GSU) announced a study published in Scientific Reports that…
-
Susan Monarez Sworn in as CDC Director
On Jul. 31, 2025, Susan Monarez, Ph.D., was sworn in as Director of the U.S. Centers for Disease…
-
CDC’s Advisory Committee on Immunization Practices Approves RSV and influenza Vaccines
On Jun. 26, 2025, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
-
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
On Jun. 25, 2025, Femasys announces Conformité Européene (CE) mark certification under European Union Medical Device Regulation of…
-
Artificial Intelligence | Biotechnology | Diagnostics | Genomics | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics
Georgia Tech, Emory University Expand Research at Science Square
On Jun. 18, 2025, Georgia Institute of Technology and Emory University announced taking medical and biomedical research to…
-
Emory study finds molecular link between air pollution and pregnancy risks
On Jun. 3, 2025, a study by Emory University researchers, published in Environmental Science & Technology, found that…
-
CDC Reports Twelve pediatric deaths from seasonal influenza virus infection
On May 2, 2025, the Centers for Disease Control reported twelve pediatric deaths associated with seasonal influenza virus…
-
CDC reported little to no immunity to H5N1 avian flu virus in Americans
On Jun. 14, 2024 the Centers for Disease Control and Prevention (CDC) reported data from this study suggested…
-
President Biden announced the appointment of Dr. Mandy Cohen as director of the CDC
On Jun. 16, 2023, President Biden announced the appointment of Dr. Mandy Cohen as Director of the Centers…
-
CDC acquired 465-acre site in Mace, West Virginia for research facility
On Mar. 21, 2023, the Centers for Disease Control and Prevention announced the acquisition of a site in…
-
Biology | CDC | Disease | Non-Profit Research | Therapeutics
CDC reported increasing threat of spread of antimicrobial-resistant fungus in healthcare facilities
On Mar. 20, 2023, the Centers for Disease Control and Prevention (CDC) reported that Candida auris (C. auris),…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
USDA confirmed highly pathogenic Avian influenza in Georgia
On Jun. 2, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service confirmed the…
-
Mandatory masking in schools reduced COVID-19 cases during Delta surge
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
-
Scientists regrow frog’s lost leg
On Jan. 26, 2022, scientists at Tufts and Harvard University’s Wyss Institute reported they were able to trigger…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 heroes & Remembrance
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | USDA | Vaccine | WHO
COVID-19 science and reason
COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…
-
COVID-19 variant vaccine trial began at KPWHRI
On Apr. 1, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that an investigational vaccine designed to…
-
Rising protocol design complexity reported driving rapid growth in clinical trial data volume
On Jan. 12, 2021, the Tufts Center for the Study of Drug Development (Tufts CSDD) reported that ever…
-
Merck and Ridgeback Bio announced collaboration to advance development of novel antiviral candidate, EIDD-2801
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
-
ADMA Biologics commenced collection of COVID-19 plasma from recovered patients
On May 21, 2020, ADMA Biologics announced it had commenced the collection of convalescent plasma through its wholly-owned…
-
The USDA announced the release of Three Joy peaches
On May 14, 2020, the U.S. Department of Agriculture (USDA) announced the Agricultural Research Service (ARS) had released…
